18VAC110-50-120: Policies and procedures
Where this section sits in the code
- Title 18. Professional And Occupational Licensing
- Agency 110. Board of Pharmacy
- Chapter 50. Regulations Governing Wholesale Distributors, Manufacturers, Third-Party Logistics Providers, and Warehousers
- Part II. Wholesale Distributors and Third-Party Logistics Providers
All wholesale distributors, nonresident wholesale distributors, third-party logistics providers, or nonresident third-party logistics providers shall establish, maintain, and adhere to written policies and procedures for the proper receipt, security, storage, inventory, and distribution of prescription drugs. Wholesale distributors, nonresident wholesale distributors, third-party logistics providers, or nonresident third-party logistics providers shall include in their policies and procedures at least the following:
1. A procedure for reporting thefts or losses of prescription drugs to the board and other appropriate authorities;
2. A procedure whereby the oldest approved stock of a prescription drug is distributed first. The procedure may permit deviation from this process provided the deviation is temporary and appropriate for the distribution;
3. A procedure for handling recalls and withdrawals of prescription drugs and devices;
4. Procedures for preparing for, protecting against, and handling emergency situations that affect the security and integrity of drugs or the operations of the wholesale distributor, nonresident wholesale distributor, third-party logistics provider, or nonresident third-party logistics provider;
5. A procedure to ensure that outdated drugs are segregated from other drugs to include the disposition of such drugs;
6. A procedure to ensure initial and ongoing training of all employees;
7. A procedure for ensuring, both initially and on an ongoing basis, that persons with access to prescription drugs have not been convicted of a violation of a drug law or any law related to wholesale distribution of prescription drugs or to third-party logistics providers; and
8. A procedure for reporting counterfeit or suspected counterfeit prescription drugs or counterfeiting or suspected counterfeiting activities to the board and other appropriate law enforcement or regulatory agencies.
Collected 2026-09-14T04:53:01Z. Source file · JSON